Celerion Receives a 2023 CRO Leadership Award in All Categor...
LINCOLN, Neb.; May 10, 2023 (Business Wire) – Celerion, a leading clinical research organization, ha...
News
Celerion Expands Its Service Offering to Include GLP/GCP Com...
LINCOLN, Neb.; Nov. 10, 2022 (Business Wire) – Celerion, a clinical research organization (CRO)...
News
CRO Leadership Award Goes to Celerion for a 7th Consecutive...
Annual survey of biopharmaceutical clients recognizes Celerion for delivering customer service excel...
News
Celerion Announces Investment in ADME Suite of Services
The leader in early clinical development expands ADME suite to meet ongoing demand. LINCOLN, Neb., A...
News
Celerion Expands Early Phase Clinical Pharmacology Units
The leader in early clinical development adds to its facilities and services to meet continually gro...
News
Tackling the Complexity of Complex Generic Drug Development
Sabina Paglialunga, PhD Director, Scientific Affairs Generic drugs account for nearly 90% of all pre...
News
Celerion Receives CRO Leadership Award for 6th Consecutive Y...
Media Contact: Michelle Maklas-Baker Associate Director, Global Marketing 1 732 306 7...
News
Is Age Just a Number? Clinical Drug Development in Older Adu...
Sabina Paglialunga, PhD Director, Scientific Affairs What Makes Older Adults So Special? Older adult...
News
Human Trials For Lyme Disease Shot Kickoff In Nebraska
About 500,000 Americans are diagnosed with Lyme disease each year. MassBiologics is developing a sho...